Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 6
1966 14
1967 8
1968 14
1969 7
1970 10
1971 13
1972 10
1973 12
1974 19
1975 17
1976 21
1977 28
1978 27
1979 46
1980 34
1981 48
1982 56
1983 71
1984 70
1985 80
1986 84
1987 86
1988 65
1989 94
1990 77
1991 83
1992 71
1993 70
1994 65
1995 62
1996 57
1997 53
1998 68
1999 55
2000 46
2001 48
2002 45
2003 56
2004 52
2005 44
2006 50
2007 60
2008 64
2009 78
2010 70
2011 80
2012 83
2013 67
2014 64
2015 52
2016 32
2017 45
2018 31
2019 22
2020 7
2021 14
2022 12
2023 13
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

2,633 results

Results by year

Filters applied: . Clear all
Page 1
Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence.
Dhayat NA, Bonny O, Roth B, Christe A, Ritter A, Mohebbi N, Faller N, Pellegrini L, Bedino G, Venzin RM, Grosse P, Hüsler C, Koneth I, Bucher C, Del Giorno R, Gabutti L, Mayr M, Odermatt U, Buchkremer F, Ernandez T, Stoermann-Chopard C, Teta D, Vogt B, Roumet M, Tamò L, Cereghetti GM, Trelle S, Fuster DG. Dhayat NA, et al. N Engl J Med. 2023 Mar 2;388(9):781-791. doi: 10.1056/NEJMoa2209275. N Engl J Med. 2023. PMID: 36856614 Free article. Clinical Trial.
METHODS: In this double-blind trial, we randomly assigned patients with recurrent calcium-containing kidney stones to receive hydrochlorothiazide at a dose of 12.5 mg, 25 mg, or 50 mg once daily or placebo once daily. ...There was no relation between the hydrochlorothia
METHODS: In this double-blind trial, we randomly assigned patients with recurrent calcium-containing kidney stones to receive hydrochloro
Oral combined hydrochlorothiazide and lisinopril vs nifedipine for postpartum hypertension: a comparative-effectiveness pilot randomized controlled trial.
Fishel Bartal M, Blackwell SC, Pedroza C, Lawal D, Amro F, Samuel J, Chauhan SP, Sibai BM. Fishel Bartal M, et al. Am J Obstet Gynecol. 2023 May;228(5):571.e1-571.e10. doi: 10.1016/j.ajog.2023.01.015. Epub 2023 Feb 12. Am J Obstet Gynecol. 2023. PMID: 36787814 Clinical Trial.
Bayesian analysis indicated an 85% posterior probability of a reduction in the primary outcome with combined hydrochlorothiazide and lisinopril therapy relative to nifedipine treatment. ...CONCLUSION: The results of the pilot trial suggest a high probability that combined …
Bayesian analysis indicated an 85% posterior probability of a reduction in the primary outcome with combined hydrochlorothiazide and …
Telmisartan and hydrochlorothiazide antihypertensive treatment in high sodium intake population: a randomized double-blind trial.
Zhang P, Wang H, Sun L, Zhang J, Xi Y, Wu Y, Yan LL, Li X, Sun N. Zhang P, et al. J Hypertens. 2017 Oct;35(10):2077-2085. doi: 10.1097/HJH.0000000000001407. J Hypertens. 2017. PMID: 28509725 Clinical Trial.
OBJECTIVES: To compare the blood pressure (BP)-lowering effects of telmisartan 40 mg/day and hydrochlorothiazide (HCTZ) 25 mg/day in high sodium intake patients with mild-to-moderate hypertension in China. ...Further studies are needed to evaluate the plausible superiority …
OBJECTIVES: To compare the blood pressure (BP)-lowering effects of telmisartan 40 mg/day and hydrochlorothiazide (HCTZ) 25 mg/day in …
An assessment of diltiazem and hydrochlorothiazide in hypertension. Application of factorial trial design to a multicenter clinical trial of combination therapy.
Burris JF, Weir MR, Oparil S, Weber M, Cady WJ, Stewart WH. Burris JF, et al. JAMA. 1990 Mar 16;263(11):1507-12. JAMA. 1990. PMID: 2407872 Clinical Trial.
This multicenter, factorial-design trial assessed the safety and additive antihypertensive efficacy of a slow-release (SR) formulation of diltiazem hydrochloride given alone or in combination with hydrochlorothiazide for treatment of mild to moderate hypertension. After a …
This multicenter, factorial-design trial assessed the safety and additive antihypertensive efficacy of a slow-release (SR) formulation of di …
Clinical trial of a new diuretic, furosemide: comparison with hydrochlorothiazide and mercaptomerin.
Godwin TF, Gunton RW. Godwin TF, et al. Can Med Assoc J. 1965 Dec 18;93(25):1296-300. Can Med Assoc J. 1965. PMID: 5320846 Free PMC article. Clinical Trial.
A clinical trial was carried out with the object of comparing the effects of furosemide, a new oral diuretic agent, with those of mercaptomerin and hydrochlorothiazide. Eleven edematous patients were chosen for the study and the diuretics were rotated, each drug being prec …
A clinical trial was carried out with the object of comparing the effects of furosemide, a new oral diuretic agent, with those of mercaptome …
The efficacy and safety of valsartan and combination of valsartan and hydrochlorothiazide in the treatment of patients with mild to moderate arterial hypertension - the VICTORY trial.
Accetto R, Chazova IY, Sirenko Y, Vincelj J, Widimsky J Jr, Barbič-Žagar B. Accetto R, et al. Kardiol Pol. 2017;75(1):55-64. doi: 10.5603/KP.a2016.0135. Epub 2016 Oct 7. Kardiol Pol. 2017. PMID: 27714718 Free article. Clinical Trial.
BACKGROUND AND AIM: The aim of the trial was to establish the efficacy and safety of Valsacor (valsartan) and Valsacombi (combination of valsartan and hydrochlorothiazide) in a wide variety of patient populations with mild to moderate arterial hypertension. ...The initial …
BACKGROUND AND AIM: The aim of the trial was to establish the efficacy and safety of Valsacor (valsartan) and Valsacombi (combination of val …
Clinical efficacy and ultrasound inspection of the treatment of hypertensive heart patients with Valsartan combined with hydrochlorothiazide.
Qian D, Tao H, Dai M, Zhang C. Qian D, et al. Pak J Pharm Sci. 2018 Jul;31(4(Special)):1659-1662. Pak J Pharm Sci. 2018. PMID: 30203756 Clinical Trial.
To observe and analyze the clinical efficacy and ultrasound detection results of treatment of hypertensive patients with heart disease with valsartan combined with hydrochlorothiazide. The 160 hypertensive patients with heart disease who were treated in our hospital were s …
To observe and analyze the clinical efficacy and ultrasound detection results of treatment of hypertensive patients with heart disease with …
Hydrochlorothiazide with or without amiloride for hypertension in the elderly. A dose-titration study.
Myers MG. Myers MG. Arch Intern Med. 1987 Jun;147(6):1026-30. Arch Intern Med. 1987. PMID: 3296979 Clinical Trial.
Ten patients receiving hydrochlorothiazide developed hypokalemia compared with only two receiving hydrochlorothiazide with amiloride. ...Hypokalemia may occur with hydrochlorothiazide alone but is much less common when hydrochlorothiazide is combined w …
Ten patients receiving hydrochlorothiazide developed hypokalemia compared with only two receiving hydrochlorothiazide with ami …
Short report: ramipril and hydrochlorothiazide combination therapy in hypertension: a clinical trial of factorial design. The East Germany Collaborative Trial Group.
Scholze J, Breitstadt A, Cairns V, Bauer B, Bender N, Priestley C, Moreadith C, Phillips J, Vander Elst E, Koch G. Scholze J, et al. J Hypertens. 1993 Feb;11(2):217-21. doi: 10.1097/00004872-199302000-00015. J Hypertens. 1993. PMID: 8385183 Clinical Trial.
OBJECTIVE: To identify appropriate dosages of ramipril and hydrochlorothiazide (HCT) when given in combination once a day for the treatment of essential hypertension. ...
OBJECTIVE: To identify appropriate dosages of ramipril and hydrochlorothiazide (HCT) when given in combination once a day for the tre …
Effect of administration of low-dose irbesartan and hydrochlorothiazide combined with levamlodipine at different times on the circadian rhythm of blood pressure and the levels of MMPs and TIMPs in non-dipper patients with grade 1 and 2 hypertension.
Yan P, Luo Y, Zhang J, Liu H, Chen J, Wang J, Dong G, Ge M. Yan P, et al. J Clin Hypertens (Greenwich). 2023 Feb;25(2):137-145. doi: 10.1111/jch.14630. Epub 2023 Jan 14. J Clin Hypertens (Greenwich). 2023. PMID: 36639984 Free PMC article. Clinical Trial.
This study aimed to probe the effects of low-dose irbesartan and hydrochlorothiazide in combination with levamlodipine at different times on the circadian rhythm of blood pressure, matrix metalloproteinases (MMPs), and tissue inhibitors of metalloproteinases (TIMPs) levels …
This study aimed to probe the effects of low-dose irbesartan and hydrochlorothiazide in combination with levamlodipine at different t …
2,633 results